000 | 02005 a2200517 4500 | ||
---|---|---|---|
005 | 20250517190133.0 | ||
264 | 0 | _c20190924 | |
008 | 201909s 0 0 eng d | ||
022 | _a1557-3265 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-17-1258 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLowery, Caitlin D | |
245 | 0 | 0 |
_aOlaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _c02 2018 |
||
300 |
_a847-857 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor alpha _xantagonists & inhibitors |
650 | 0 | 4 |
_aSarcoma _xdrug therapy |
650 | 0 | 4 |
_aSoft Tissue Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aBlosser, Wayne | |
700 | 1 | _aDowless, Michele | |
700 | 1 | _aKnoche, Shelby | |
700 | 1 | _aStephens, Jennifer | |
700 | 1 | _aLi, Huiling | |
700 | 1 | _aSurguladze, David | |
700 | 1 | _aLoizos, Nick | |
700 | 1 | _aLuffer-Atlas, Debra | |
700 | 1 | _aOakley, Gerard J | |
700 | 1 | _aGuo, Qianxu | |
700 | 1 | _aIyer, Seema | |
700 | 1 | _aRubin, Brian P | |
700 | 1 | _aStancato, Louis | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 24 _gno. 4 _gp. 847-857 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-17-1258 _zAvailable from publisher's website |
999 |
_c27841348 _d27841348 |